Medizin - Open Access LMU - Teil 16/22

Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy - a case report


Listen Later

Background: Membrane-bound heat shock protein 70 (Hsp70) serves as a tumor-specific recognition structure for Hsp70-peptide (TKD) plus IL-2 activated NK cells. A phase I clinical trial has shown that repeated re-infusions of ex vivo TKD/IL-2-activated, autologous leukapheresis product is safe. This study investigated the maintenance of the cytolytic activity of NK cells against K562 cells and autologous tumor after 6 plus 3 infusions of TKD/IL-2-activated effector cells. Methods: A stable tumor cell line was generated from the resected anastomotic relapse of a patient with colon carcinoma (pT3, N2, M0, G2). Two months after surgery, the patient received the first monthly i.v. infusion of his ex vivo TKD/IL-2-activated peripheral blood mononuclear cells (PBMNC). After 6 infusions and a pause of 3 months, the patient received another 3 cell infusions. The phenotypic characteristics and activation status of tumor and effector cells were determined immediately before and at times after each infusion. Results: The NK cell ligands Hsp70, MICA/B, and ULBP-1,2,3 were expressed on the patient's anastomotic relapse. An increased density of activatory NK cell receptors following ex vivo stimulation correlated with an enhanced anti-tumoricidal activity. After 4 re-infusion cycles, the intrinsic cytolytic activity of non-stimulated PBMNC was significantly elevated and this heightened responsiveness persisted for up to 3 months after the last infusion. Another 2 re-stimulations with TKD/IL-2 restored the cytolytic activity after the therapeutic pause. Conclusion: In a patient with colon carcinoma, repeated infusions of ex vivo TKD/IL-2-activated PBMNC initiate an intrinsic NK cell-mediated cytolytic activity against autologous tumor cells.
...more
View all episodesView all episodes
Download on the App Store

Medizin - Open Access LMU - Teil 16/22By Ludwig-Maximilians-Universität München


More shows like Medizin - Open Access LMU - Teil 16/22

View all
Geld und Leben - Ringvorlesung (WiSe 2009-2010) by Ludwig-Maximilians-Universität München

Geld und Leben - Ringvorlesung (WiSe 2009-2010)

0 Listeners

MCMP – Mathematical Philosophy (Archive 2011/12) by MCMP Team

MCMP – Mathematical Philosophy (Archive 2011/12)

6 Listeners

Hegel lectures by Robert Brandom, LMU Munich by Robert Brandom, Axel Hutter

Hegel lectures by Robert Brandom, LMU Munich

6 Listeners

LMU Statistik I für Studierende der Wirtschaftswissenschaften by PD Dr. Christian Heumann

LMU Statistik I für Studierende der Wirtschaftswissenschaften

0 Listeners

Institut für Produktionswirtschaft und Controlling (LMU) by Prof. Dr. Dr. h.c. Hans-Ulrich Küpper

Institut für Produktionswirtschaft und Controlling (LMU)

0 Listeners

Center for Advanced Studies (CAS) Cutting Edge - SD by Center for Advanced Studies (CAS)

Center for Advanced Studies (CAS) Cutting Edge - SD

0 Listeners

LMU Rechtsphilosophie by Prof. Dr. jur. Dr. jur. h.c. mult. Bernd Schünemann

LMU Rechtsphilosophie

0 Listeners

MCMP – Philosophy of Science by MCMP Team

MCMP – Philosophy of Science

1 Listeners

LMU Physik 2 für Chemiker (PN2) SS2016 by Prof. Dr. Jan Lipfert

LMU Physik 2 für Chemiker (PN2) SS2016

0 Listeners

Fakultät für Chemie und Pharmazie - Digitale Hochschulschriften der LMU - Teil 05/06 by Ludwig-Maximilians-Universität München

Fakultät für Chemie und Pharmazie - Digitale Hochschulschriften der LMU - Teil 05/06

0 Listeners